BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines.

A popular DNA sequencer has been found carrying a vulnerability allowing threat actors to establish persistence on the device, destroy the hardware, or even tamper with the results, experts have ...

The iSeq 100, developed by manufacturer Illumina, was torn down and found to be running an insecure BIOS implementation that opened up the device to malware and ransomware attacks, as well as ...

Eclypsium security researchers have uncovered UEFI vulnerabilities in the Illumina iSeq 100 DNA sequencer, but the broader issue involves the device development process at large.

BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines.

The FTSE 100 was testing record highs after Trump’s address to the World Economic Forum sent a pulse of optimism across ...

Certain vulnerabilities in device maker Illumina's iSeq 100 DNA gene sequencer could allow hackers to overwrite the system's ...

The Iseq All Share index rose 0.9 per cent to 9,771.73, with banking and construction stocks gaining ground. AIB moved 1.6 ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...